AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiauk M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Auk Lifecare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimiauk M 1mg/500mg Tablet

Diabexe Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels and potential complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is one component of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, manifesting as sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular meals and carry a rapid-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimiauk M 1mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glimiauk M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimiauk M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimiauk M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimiauk M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiauk M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Glimiauk M 1mg/500mg Tablet with a meal.

How Glimiauk M 1mg/500mg Tablet works:

Glimiauk M 1mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimiauk M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimiauk M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Glimiauk M 1mg/500mg tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimiauk M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Glimiauk M 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimiauk M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Low initial doses are typically prescribed for those with mild to moderate hepatic dysfunction; the medication is contraindicated in patients with severe liver disease.

What if you forget to take Glimiauk M 1mg/500mg Tablet :

Should you forget to take a Glimiauk M 1mg/500mg Tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimiauk M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimiauk M 1mg/500mg Tablet

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Glimiauk M 1mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms may present as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Glimiauk M 1mg/500mg Tablet use and seek immediate medical attention.
Glimepiride/Metformin 1mg/500mg tablets (e.g., Glimiuk M) combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This dual therapy enhances glycemic control when coupled with a suitable diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose output and augmenting insulin sensitivity. This formulation is unsuitable for treating type 1 diabetes.
Glimiauk M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Indeed, prolonged consumption of Glimiauk M 1mg/500mg Tablets can lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake is recommended annually by some experts.
Glimiauk M 1mg/500mg Tablets can induce hypoglycemia (low blood glucose). This may manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carry a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimiauk M 1mg/500mg tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol use also elevates the likelihood of lactic acidosis.
Glimiauk M 1mg/500mg Tabl...
33
MRP 40
18% off